AskNiveshLive·11:19 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to MANKIND

Mankind Pharma Ltd.: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsMar-25Jun-25Sep-25Dec-25Mar-26
Revenue
3,0793,5703,6973,5673,443
Other income
251809273114
Expenses
2,8183,1133,1673,0282,878
Cost of materials consumed
554586594553555
Purchases of stock-in-trade
411405413412498
Change in inventories
-90635513-95
Employee benefit expense
716783825824752
Finance costs
191171170157142
Depreciation & amortisation
231219222223223
Other expenses
805887888846803
EBITDA
9359271,0148861,021
EBIT
704708792663798
Exceptional items
----107-23
Profit Before Tax
513537622506656
Tax expense
869610495100
Deferred tax
-45-15-21-59-93
Net Profit
425445520414559
Financial Ratios
Operating Profit Margin
22.86%19.83%21.42%18.59%23.18%
EBITDA Margin
30.37%25.97%27.43%24.84%29.65%
Net Profit Margin
13.80%12.46%14.07%11.61%16.24%
Earnings Per Share (₹)
10.1910.6212.399.9013.44

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.